What is McLaughlin & Lauricella?
McLaughlin & Lauricella is a premier Philadelphia and New Jersey-based law firm that has established a reputation for excellence in the fields of medical malpractice, motor vehicle accidents, and sexual abuse litigation. Under the leadership of founders Slade McLaughlin and Paul Lauricella, both of whom are board-certified trial attorneys, the firm has cultivated a specialized practice focused on catastrophic injury and medical negligence. Their market position is defined by a commitment to securing justice for victims of systemic failure and professional negligence, utilizing a team of highly skilled legal associates to navigate the complexities of multi-jurisdictional litigation. The firm's expertise in misdiagnosis and medical error cases positions it as a critical player in the regional legal sector, consistently delivering results for clients seeking fair compensation.
How much funding has McLaughlin & Lauricella raised?
McLaughlin & Lauricella has raised a total of $489K across 2 funding rounds:
Debt
$150K
Debt
$339K
Debt (2020): $150K with participation from PPP
Debt (2021): $339K led by PPP
Key Investors in McLaughlin & Lauricella
PPP
Public-Private Partnership
What's next for McLaughlin & Lauricella?
With the recent influx of capital, McLaughlin & Lauricella is well-positioned to expand its litigation capabilities and further invest in the specialized resources required for complex medical malpractice trials. The firm's strategic focus will likely remain on enhancing its trial advocacy infrastructure and increasing its capacity to handle a higher volume of catastrophic injury claims. By maintaining a strong balance sheet through disciplined debt management, the firm is prepared to sustain its long-term growth objectives while continuing to provide high-level legal representation. Future initiatives will likely involve the integration of advanced case management technologies and the continued recruitment of top-tier legal talent to maintain its competitive edge in the personal injury and medical negligence markets.
See full McLaughlin & Lauricella company page
